Mereo BioPharma Group plc (MREO) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $40.99M | -41.3% |
| 2024 | $69.80M | +21.6% |
| 2023 | $57.42M | -15.8% |
| 2022 | $68.18M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $40.99M | -41.3% |
| 2024 | $69.80M | +21.6% |
| 2023 | $57.42M | -15.8% |
| 2022 | $68.18M | — |